Skip to main content
. 2017 Sep;5(17):348. doi: 10.21037/atm.2017.06.35

Figure 1.

Figure 1

Algorithm for LVEF monitoring with MUGA to prevent doxorubicin induced cardiotoxicity. *, risk factors include known heart disease, radiation exposure, treatment with high dose cyclophosphamide, and electrocardiographic abnormalities. MUGA, multigated acquisition.